南京诺唯赞生物科技股份有限公司关于以集中竞价交易方式回购公司股份的进展公告

Group 1 - The company approved a share repurchase plan on June 19, 2025, with a budget between RMB 5 million and RMB 10 million, aiming to buy back its A-shares at a price not exceeding RMB 30 per share within 12 months [1][3]. - As of June 30, 2025, the company has not yet implemented the share repurchase [2]. - The company will adhere to relevant regulations and will make repurchase decisions based on market conditions, ensuring timely disclosure of progress to investors [3].